Vascular Biogenics Ltd. is a biopharmaceutical company that specializes in the development and commercialization of gene therapy treatments for cancer. With a focus on vascular targeting and angiogenesis, the company aims to revolutionize cancer therapies by delivering targeted and effective treatments to patients in need.
